Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 116

1.

Axl-Targeted Delivery of the Oncosuppressor miR-137 in Non-small-Cell Lung Cancer.

Nuzzo S, Catuogno S, Capuozzo M, Fiorelli A, Swiderski P, Boccella S, de Nigris F, Esposito CL.

Mol Ther Nucleic Acids. 2019 Jun 13;17:256-263. doi: 10.1016/j.omtn.2019.06.002. [Epub ahead of print]

2.

Retraction: FRA-1 Expression in Hyperplastic and Neoplastic Thyroid Diseases.

Chiappetta G, Tallini G, De Biasio MC, Pentimalli F, de Nigris F, Losito S, Fedele M, Battista S, Verde P, Santoro M, Fusco A.

Clin Cancer Res. 2019 Apr 15;25(8):2675. doi: 10.1158/1078-0432.CCR-19-0487. No abstract available.

PMID:
30988099
3.

Endoanchors under 3D image fusion for a type IA endoleak after EVAR.

Tinelli G, De Nigris F, Minelli F, Flore R, Santoliquido A, Tshomba Y.

Clin Case Rep. 2019 Feb 6;7(3):529-532. doi: 10.1002/ccr3.2033. eCollection 2019 Mar.

4.

New challenges in integrated diagnosis by imaging and osteo-immunology in bone lesions.

Schiano C, Soricelli A, De Nigris F, Napoli C.

Expert Rev Clin Immunol. 2019 Mar;15(3):289-301. doi: 10.1080/1744666X.2019.1561283. Epub 2019 Jan 2.

PMID:
30570412
5.

Epigenetic Hallmarks of Fetal Early Atherosclerotic Lesions in Humans.

de Nigris F, Cacciatore F, Mancini FP, Vitale DF, Mansueto G, D'Armiento FP, Schiano C, Soricelli A, Napoli C.

JAMA Cardiol. 2018 Nov 7. doi: 10.1001/jamacardio.2018.3546. [Epub ahead of print]

PMID:
30419118
6.

Quantitative digital subtraction angiography to localize intercostal arteries during thoracic endovascular aortic repair.

Tinelli G, Minelli F, De Nigris F, Flex A.

J Vasc Surg Cases Innov Tech. 2018 Feb 13;4(1):35-36. doi: 10.1016/j.jvscit.2017.10.003. eCollection 2018 Mar. No abstract available.

7.

STAT3 Gene Silencing by Aptamer-siRNA Chimera as Selective Therapeutic for Glioblastoma.

Esposito CL, Nuzzo S, Catuogno S, Romano S, de Nigris F, de Franciscis V.

Mol Ther Nucleic Acids. 2018 Mar 2;10:398-411. doi: 10.1016/j.omtn.2017.12.021. Epub 2017 Dec 30.

8.

Sarcoma Spheroids and Organoids-Promising Tools in the Era of Personalized Medicine.

Colella G, Fazioli F, Gallo M, De Chiara A, Apice G, Ruosi C, Cimmino A, de Nigris F.

Int J Mol Sci. 2018 Feb 21;19(2). pii: E615. doi: 10.3390/ijms19020615. Review.

9.

The potential role of quantitative digital subtraction angiography in evaluating type B chronic aortic dissection during TEVAR: preliminary results.

Tinelli G, Minelli F, De Nigris F, Vincenzoni C, Filipponi M, Bruno P, Massetti M, Flex A, Iezzi R.

Eur Rev Med Pharmacol Sci. 2018 Jan;22(2):516-522. doi: 10.26355/eurrev_201801_14204.

10.

Post-surgery fluids promote transition of cancer stem cell-to-endothelial and AKT/mTOR activity, contributing to relapse of giant cell tumors of bone.

Fazioli F, Colella G, Miceli R, Di Salvatore MG, Gallo M, Boccella S, De Chiara A, Ruosi C, de Nigris F.

Oncotarget. 2017 Jun 28;8(49):85040-85053. doi: 10.18632/oncotarget.18783. eCollection 2017 Oct 17.

11.

Images in Vascular Medicine: Quantitative digital subtraction angiography during type B chronic aortic dissection endovascular repair.

Tinelli G, De Nigris F, Minelli F, Vincenzoni C, Flex A.

Vasc Med. 2018 Apr;23(2):181-182. doi: 10.1177/1358863X17737167. Epub 2017 Oct 24. No abstract available.

PMID:
29065789
12.

Analysis of Italian regulations on pathways of care for patients in a vegetative or minimally conscious state.

Sattin D, De Torres L, Dolce G, Arcuri F, Estraneo A, Cardinale V, Piperno R, Zavatta E, Formisano R, D'Ippolito M, Vassallo C, Dessi B, Lamberti G, Antoniono E, Lanzillotti C, Navarro J, Bramanti P, Marino S, Zampolini M, Scarponi F, Avesani R, Salvi L, Ferro S, Mazza L, Fogar P, Feller S, De Nigris F, Martinuzzi A, Buffoni M, Pessina A, Corsico P, Leonardi M.

Funct Neurol. 2017 Jul/Sep;32(3):159-163.

13.

The role of a new class of long noncoding RNAs transcribed from ultraconserved regions in cancer.

Terracciano D, Terreri S, de Nigris F, Costa V, Calin GA, Cimmino A.

Biochim Biophys Acta Rev Cancer. 2017 Dec;1868(2):449-455. doi: 10.1016/j.bbcan.2017.09.001. Epub 2017 Sep 13. Review.

PMID:
28916343
14.

Care pathways models and clinical outcomes in Disorders of consciousness.

Sattin D, Morganti L, De Torres L, Dolce G, Arcuri F, Estraneo A, Cardinale V, Piperno R, Zavatta E, Formisano R, D'Ippolito M, Vassallo C, Dessi B, Lamberti G, Antoniono E, Lanzillotti C, Navarro J, Bramanti P, Corallo F, Zampolini M, Scarponi F, Avesani R, Salvi L, Ferro S, Mazza L, Fogar P, Feller S, De Nigris F, Martinuzzi A, Buffoni M, Pessina A, Corsico P, Leonardi M.

Brain Behav. 2017 Jul 21;7(8):e00740. doi: 10.1002/brb3.740. eCollection 2017 Aug.

15.

Lectin Pathway of Complement Activation Is Associated with Vulnerability of Atherosclerotic Plaques.

Fumagalli S, Perego C, Zangari R, De Blasio D, Oggioni M, De Nigris F, Snider F, Garred P, Ferrante AM, De Simoni MG.

Front Immunol. 2017 Mar 16;8:288. doi: 10.3389/fimmu.2017.00288. eCollection 2017.

16.

Yin Yang I as an Epimodulator of miRNAs in the Metastatic Cascade.

Ruosi C, Colella G, Fazioli F, Miceli R, Gallo M, Di Salvatore MG, Cimmino A, de Nigris F.

Crit Rev Oncog. 2017;22(1-2):99-107. doi: 10.1615/CritRevOncog.2017020855. Review.

PMID:
29604939
17.

New Cross-Talk Layer between Ultraconserved Non-Coding RNAs, MicroRNAs and Polycomb Protein YY1 in Bladder Cancer.

Terreri S, Durso M, Colonna V, Romanelli A, Terracciano D, Ferro M, Perdonà S, Castaldo L, Febbraio F, de Nigris F, Cimmino A.

Genes (Basel). 2016 Dec 14;7(12). pii: E127.

18.

Epigenetic regulators: Polycomb-miRNA circuits in cancer.

de Nigris F.

Biochim Biophys Acta. 2016 May;1859(5):697-704. doi: 10.1016/j.bbagrm.2016.03.005. Epub 2016 Mar 11. Review.

PMID:
26975854
19.

Homotaurine in Parkinson's disease.

Ricciardi L, De Nigris F, Specchia A, Fasano A.

Neurol Sci. 2015 Sep;36(9):1581-7. doi: 10.1007/s10072-015-2201-6. Epub 2015 Apr 19.

PMID:
25894843
20.

Polycomb YY1 is a critical interface between epigenetic code and miRNA machinery after exposure to hypoxia in malignancy.

Infante T, Mancini FP, Lanza A, Soricelli A, de Nigris F, Napoli C.

Biochim Biophys Acta. 2015 May;1853(5):975-86. doi: 10.1016/j.bbamcr.2015.01.009. Epub 2015 Jan 30.

21.

Involvement of Mediator complex in malignancy.

Schiano C, Casamassimi A, Rienzo M, de Nigris F, Sommese L, Napoli C.

Biochim Biophys Acta. 2014 Jan;1845(1):66-83. doi: 10.1016/j.bbcan.2013.12.001. Epub 2013 Dec 14. Review.

PMID:
24342527
22.

Ex vivo behaviour of human bone tumor endothelial cells.

Infante T, Cesario E, Gallo M, Fazioli F, De Chiara A, Tutucci C, Apice G, de Nigris F.

Cancers (Basel). 2013 Apr 11;5(2):404-17. doi: 10.3390/cancers5020404.

23.

Epidemiological, clinical, and molecular study of a cohort of Italian Parkinson disease patients: association with glutathione-S-transferase and DNA repair gene polymorphisms.

Cornetta T, Patrono C, Terrenato I, De Nigris F, Bentivoglio AR, Testa A, Palma V, Poggioli T, Padua L, Cozzi R.

Cell Mol Neurobiol. 2013 Jul;33(5):673-80. doi: 10.1007/s10571-013-9933-8. Epub 2013 Apr 4.

PMID:
23552977
24.

Neuropsychological features of patients with Parkinson's disease and impulse control disorders.

Bentivoglio AR, Baldonero E, Ricciardi L, De Nigris F, Daniele A.

Neurol Sci. 2013 Jul;34(7):1207-13. doi: 10.1007/s10072-012-1224-5. Epub 2012 Nov 18.

PMID:
23161255
25.

Osteosarcoma cells induce endothelial cell proliferation during neo-angiogenesis.

de Nigris F, Mancini FP, Schiano C, Infante T, Zullo A, Minucci PB, Al-Omran M, Giordano A, Napoli C.

J Cell Physiol. 2013 Apr;228(4):846-52. doi: 10.1002/jcp.24234.

PMID:
23042366
26.

CXCR4 inhibitors: tumor vasculature and therapeutic challenges.

de Nigris F, Schiano C, Infante T, Napoli C.

Recent Pat Anticancer Drug Discov. 2012 Sep;7(3):251-64. Review.

PMID:
22376154
27.

Glycoxydation promotes vascular damage via MAPK-ERK/JNK pathways.

de Nigris F, Rienzo M, Sessa M, Infante T, Cesario E, Ignarro LJ, Al-Omran M, Giordano A, Palinski W, Napoli C.

J Cell Physiol. 2012 Nov;227(11):3639-47. doi: 10.1002/jcp.24070.

PMID:
22331607
28.

Safety and efficacy of rotigotine in individuals with Parkinson's disease aged 75 and older.

Fasano A, Guidubaldi A, De Nigris F, Bentivoglio AR.

J Am Geriatr Soc. 2011 Dec;59(12):2386-7. doi: 10.1111/j.1532-5415.2011.03689.x. No abstract available.

PMID:
22188090
29.

YY1 overexpression is associated with poor prognosis and metastasis-free survival in patients suffering osteosarcoma.

de Nigris F, Zanella L, Cacciatore F, De Chiara A, Fazioli F, Chiappetta G, Apice G, Infante T, Monaco M, Rossiello R, De Rosa G, Alberghini M, Napoli C.

BMC Cancer. 2011 Nov 2;11:472. doi: 10.1186/1471-2407-11-472.

30.

Role of sepiapterin reductase gene at the PARK3 locus in Parkinson's disease.

Sharma M, Maraganore DM, Ioannidis JP, Riess O, Aasly JO, Annesi G, Abahuni N, Bentivoglio AR, Brice A, Van Broeckhoven C, Chartier-Harlin MC, Destée A, Djarmati A, Elbaz A, Farrer M, Ferrarese C, Gibson JM, Gispert S, Hattori N, Jasinska-Myga B, Klein C, Lesage S, Lynch T, Lichtner P, Lambert JC, Lang AE, Mellick GD, De Nigris F, Opala G, Quattrone A, Riva C, Rogaeva E, Ross OA, Satake W, Silburn PA, Theuns J, Toda T, Tomiyama H, Uitti RJ, Wirdefeldt K, Wszolek Z, Gasser T, Krüger R; Genetic Epidemiology of Parkinson's Disease Consortium.

Neurobiol Aging. 2011 Nov;32(11):2108.e1-5. doi: 10.1016/j.neurobiolaging.2011.05.024. Epub 2011 Jul 22.

PMID:
21782285
31.

Retrospective evaluation of the dose equivalence of Botox(®) and Dysport (®) in the management of blepharospasm and hemifacial spasm: a novel paradigm for a never ending story.

Bentivoglio AR, Ialongo T, Bove F, De Nigris F, Fasano A.

Neurol Sci. 2012 Apr;33(2):261-7. doi: 10.1007/s10072-011-0672-7. Epub 2011 Jun 28.

PMID:
21710123
32.

Effects of ACE inhibition on circulating endothelial progenitor cells, vascular damage, and oxidative stress in hypertensive patients.

Cacciatore F, Bruzzese G, Vitale DF, Liguori A, de Nigris F, Fiorito C, Infante T, Donatelli F, Minucci PB, Ignarro LJ, Napoli C.

Eur J Clin Pharmacol. 2011 Sep;67(9):877-83. doi: 10.1007/s00228-011-1029-0. Epub 2011 Mar 29.

PMID:
21445638
33.

Directed in vivo angiogenesis assay and the study of systemic neoangiogenesis in cancer.

Napoli C, Giordano A, Casamassimi A, Pentimalli F, Ignarro LJ, De Nigris F.

Int J Cancer. 2011 Apr 1;128(7):1505-8. doi: 10.1002/ijc.25743. Epub 2011 Jan 6. Review.

34.

CXCR4/YY1 inhibition impairs VEGF network and angiogenesis during malignancy.

de Nigris F, Crudele V, Giovane A, Casamassimi A, Giordano A, Garban HJ, Cacciatore F, Pentimalli F, Marquez-Garban DC, Petrillo A, Cito L, Sommese L, Fiore A, Petrillo M, Siani A, Barbieri A, Arra C, Rengo F, Hayashi T, Al-Omran M, Ignarro LJ, Napoli C.

Proc Natl Acad Sci U S A. 2010 Aug 10;107(32):14484-9. doi: 10.1073/pnas.1008256107. Epub 2010 Jul 26. Erratum in: Proc Natl Acad Sci U S A. 2019 Apr 9;116(15):7594-7597.

35.

A large-scale genetic association study to evaluate the contribution of Omi/HtrA2 (PARK13) to Parkinson's disease.

Krüger R, Sharma M, Riess O, Gasser T, Van Broeckhoven C, Theuns J, Aasly J, Annesi G, Bentivoglio AR, Brice A, Djarmati A, Elbaz A, Farrer M, Ferrarese C, Gibson JM, Hadjigeorgiou GM, Hattori N, Ioannidis JP, Jasinska-Myga B, Klein C, Lambert JC, Lesage S, Lin JJ, Lynch T, Mellick GD, de Nigris F, Opala G, Prigione A, Quattrone A, Ross OA, Satake W, Silburn PA, Tan EK, Toda T, Tomiyama H, Wirdefeldt K, Wszolek Z, Xiromerisiou G, Maraganore DM; Genetic Epidemiology of Parkinson's disease consortium.

Neurobiol Aging. 2011 Mar;32(3):548.e9-18. doi: 10.1016/j.neurobiolaging.2009.11.021. Epub 2009 Dec 24.

36.

Therapeutic angiogenesis in diabetic apolipoprotein E-deficient mice using bone marrow cells, functional hemangioblasts and metabolic intervention.

Balestrieri ML, Lu SJ, de Nigris F, Giovane A, Williams-Ignarro S, D'Armiento FP, Feng Q, Fiorito C, Testa G, Pastore L, Cacciatore F, Mancini FP, Servillo L, De Rosa G, Pagliarulo C, Rienzo M, Minucci PB, Farzati B, Salvatore F, Rengo F, Ignarro LJ, Giordano A, Baker A, Lanza R, Napoli C.

Atherosclerosis. 2010 Apr;209(2):403-14. doi: 10.1016/j.atherosclerosis.2009.10.022. Epub 2009 Oct 29.

PMID:
19932479
37.

p66Shc deletion confers vascular protection in advanced atherosclerosis in hypercholesterolemic apolipoprotein E knockout mice.

Martin-Padura I, de Nigris F, Migliaccio E, Mansueto G, Minardi S, Rienzo M, Lerman LO, Stendardo M, Giorgio M, De Rosa G, Pelicci PG, Napoli C.

Endothelium. 2008 Sep-Oct;15(5-6):276-87. doi: 10.1080/10623320802487791.

PMID:
19065319
38.

Long-term treatment with sulfhydryl angiotensin-converting enzyme inhibition reduces carotid intima-media thickening and improves the nitric oxide/oxidative stress pathways in newly diagnosed patients with mild to moderate primary hypertension.

Napoli C, Bruzzese G, Ignarro LJ, Crimi E, de Nigris F, Williams-Ignarro S, Libardi S, Sommese L, Fiorito C, Mancini FP, Cacciatore F, Liguori A.

Am Heart J. 2008 Dec;156(6):1154.e1-8. doi: 10.1016/j.ahj.2008.09.006.

PMID:
19033012
39.

Silencing of YY1 downregulates RIZ1 promoter in human osteosarcoma.

Abbondanza C, de Nigris F, De Rosa C, Rossiello R, Puca GA, Napoli C.

Oncol Res. 2008;17(1):33-41.

PMID:
18488713
40.

Therapeutic dose of nebivolol, a nitric oxide-releasing beta-blocker, reduces atherosclerosis in cholesterol-fed rabbits.

de Nigris F, Mancini FP, Balestrieri ML, Byrns R, Fiorito C, Williams-Ignarro S, Palagiano A, Crimi E, Ignarro LJ, Napoli C.

Nitric Oxide. 2008 Aug;19(1):57-63. doi: 10.1016/j.niox.2008.03.004. Epub 2008 Apr 4.

PMID:
18435936
41.

Therapeutic targeting of the stem cell niche in experimental hindlimb ischemia.

Napoli C, William-Ignarro S, Byrns R, Balestrieri ML, Crimi E, Farzati B, Mancini FP, de Nigris F, Matarazzo A, D'Amora M, Abbondanza C, Fiorito C, Giovane A, Florio A, Varricchio E, Palagiano A, Minucci PB, Tecce MF, Giordano A, Pavan A, Ignarro LJ.

Nat Clin Pract Cardiovasc Med. 2008 Sep;5(9):571-9. doi: 10.1038/ncpcardio1214. Epub 2008 Apr 15.

PMID:
18414452
42.

Deletion of Yin Yang 1 protein in osteosarcoma cells on cell invasion and CXCR4/angiogenesis and metastasis.

de Nigris F, Rossiello R, Schiano C, Arra C, Williams-Ignarro S, Barbieri A, Lanza A, Balestrieri A, Giuliano MT, Ignarro LJ, Napoli C.

Cancer Res. 2008 Mar 15;68(6):1797-808. doi: 10.1158/0008-5472.CAN-07-5582.

43.

Evidence of key role of Cdk2 overexpression in pemphigus vulgaris.

Lanza A, Cirillo N, Rossiello R, Rienzo M, Cutillo L, Casamassimi A, de Nigris F, Schiano C, Rossiello L, Femiano F, Gombos F, Napoli C.

J Biol Chem. 2008 Mar 28;283(13):8736-45. doi: 10.1074/jbc.M702186200. Epub 2008 Jan 16.

44.

Prominent cardioprotective effects of third generation beta blocker nebivolol against anthracycline-induced cardiotoxicity using the model of isolated perfused rat heart.

de Nigris F, Rienzo M, Schiano C, Fiorito C, Casamassimi A, Napoli C.

Eur J Cancer. 2008 Feb;44(3):334-40. doi: 10.1016/j.ejca.2007.12.010. Epub 2008 Jan 14.

PMID:
18194856
45.

Therapeutic effects of autologous bone marrow cells and metabolic intervention in the ischemic hindlimb of spontaneously hypertensive rats involve reduced cell senescence and CXCR4/Akt/eNOS pathways.

de Nigris F, Balestrieri ML, Williams-Ignarro S, D'Armiento FP, Lerman LO, Byrns R, Crimi E, Palagiano A, Fatigati G, Ignarro LJ, Napoli C.

J Cardiovasc Pharmacol. 2007 Oct;50(4):424-33.

PMID:
18049311
46.

Effect of gestational hypercholesterolaemia on omental vasoreactivity, placental enzyme activity and transplacental passage of normal and oxidised fatty acids.

Liguori A, D'Armiento FP, Palagiano A, Balestrieri ML, Williams-Ignarro S, de Nigris F, Lerman LO, D'Amora M, Rienzo M, Fiorito C, Ignarro LJ, Palinski W, Napoli C.

BJOG. 2007 Dec;114(12):1547-56. Epub 2007 Sep 27.

47.

The influence of pomegranate fruit extract in comparison to regular pomegranate juice and seed oil on nitric oxide and arterial function in obese Zucker rats.

de Nigris F, Balestrieri ML, Williams-Ignarro S, D'Armiento FP, Fiorito C, Ignarro LJ, Napoli C.

Nitric Oxide. 2007 Aug;17(1):50-4. Epub 2007 May 5.

PMID:
17553710
48.

Brain protection using autologous bone marrow cell, metalloproteinase inhibitors, and metabolic treatment in cerebral ischemia.

Baker AH, Sica V, Work LM, Williams-Ignarro S, de Nigris F, Lerman LO, Casamassimi A, Lanza A, Schiano C, Rienzo M, Ignarro LJ, Napoli C.

Proc Natl Acad Sci U S A. 2007 Feb 27;104(9):3597-602. Epub 2007 Feb 20.

49.

Autologous bone marrow cell therapy and metabolic intervention in ischemia-induced angiogenesis in the diabetic mouse hindlimb.

Sica V, Williams-Ignarro S, de Nigris F, D'Armiento FP, Lerman LO, Balestrieri ML, Maione C, Palagiano A, Rossiello L, Ignarro LJ, Napoli C.

Cell Cycle. 2006 Dec;5(24):2903-8. Epub 2006 Dec 15.

PMID:
17172874
50.

Rethinking primary prevention of atherosclerosis-related diseases.

Napoli C, Lerman LO, de Nigris F, Gossl M, Balestrieri ML, Lerman A.

Circulation. 2006 Dec 5;114(23):2517-27. Review. No abstract available.

PMID:
17146003

Supplemental Content

Loading ...
Support Center